Enrolling By InvitationNCT06916403
Safety and Efficacy of Ketamine Intravenous Infusions in the Treatment of Fibromyalgia
Observational studyAges 18+CanadaDepression
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- ThornhillSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: November 30, 2020
- Recruitment status
- Enrolling By Invitation
- Enrollment listed in the registry
- 50
- Sponsor
- Wilderman Medical Clinic
- Sponsor type
- Hospital / academic medical center
- Study type
- Observational
- Intervention type
- Drug
- Locations
- Canada
- Age range
- Over 18 Years
- Official registry ID
- NCT06916403
- Official title
Show the full official title
A Two-part Study to Access the Safety and Efficacy of Ketamine Intravenous Infusions in the Treatment of Fibromyalgia
Recruitment & locations
By invitationThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Thornhill
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Wilderman Medical Clinic, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including Intravenous Ketamine Infusions.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as enrolling by invitation.
